UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
Marten Transport
MRTN
$1.22B
| $1.45M | ﹤0.01% |
93,038
+66,379
| +249% | +$1.11M |
|
5002
Inogen
INGN
$164M
| $1.45M | ﹤0.01% |
157,907
+106,398
| +207% | +$995K |
|
5003
ARK Space & Defense Innovation ETF
ARKX
$850M
| $1.45M | ﹤0.01% |
74,167
+56,544
| +321% | +$1.02M |
|
5004
ALPS Equal Sector Weight ETF
EQL
$762M
| $1.45M | ﹤0.01% |
34,620
-9,351
| -21% | -$402K |
|
|
MQT
5005
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $1.45M | ﹤0.01% |
146,560
-43,252
| -23% | -$451K |
|
5006
Manitowoc
MTW
$675M
| $1.44M | ﹤0.01% |
158,155
+133,638
| +545% | +$1.32M |
|
5007
ICL Group
ICL
$6.85B
| $1.44M | ﹤0.01% |
292,272
-3,039,143
| -91% | -$13.6M |
|
5008
Civista Bancshares
CIVB
$589M
| $1.44M | ﹤0.01% |
68,520
+56,610
| +475% | +$1.17M |
|
|
STEW
5009
SRH Total Return Fund
STEW
$1.81B
| $1.44M | ﹤0.01% |
89,836
+8,808
| +11% | +$142K |
|
5010
NB Bancorp
NBBK
$989M
| $1.44M | ﹤0.01% |
79,656
+7,056
| +10% | +$136K |
|
|
BNY
5011
DELISTED
BlackRock New York Municipal Income Trust
BNY
| $1.43M | ﹤0.01% |
140,744
+31,133
| +28% | +$332K |
|
5012
iShares S&P GSCI Commodity-Indexed Trust
GSG
$900M
| $1.43M | ﹤0.01% |
65,809
-3,869
| -6% | -$82.5K |
|
5013
ProShares Ultra Bloomberg Crude Oil
UCO
$385M
| $1.43M | ﹤0.01% |
+52,000
| New | +$1.38M |
|
|
ECC
5014
Eagle Point Credit Company
ECC
$513M
| $1.43M | ﹤0.01% |
160,790
+147,685
| +1,127% | +$1.38M |
|
5015
Forestar Group
FOR
$1.51B
| $1.43M | ﹤0.01% |
55,070
+31,388
| +133% | +$939K |
|
|
TE
5016
T1 Energy
TE
$1.63B
| $1.42M | ﹤0.01% |
552,039
+499,269
| +946% | +$838K |
|
5017
Conduent
CNDT
$264M
| $1.42M | ﹤0.01% |
351,752
+235,153
| +202% | +$935K |
|
5018
PUT
Fastly Inc
FSLY
$3.66B
| $1.42M | ﹤0.01% |
150,200
+50,000
| +50% | +$415K |
|
5019
Editas Medicine
EDIT
$442M
| $1.42M | ﹤0.01% |
1,115,080
+704,471
| +172% | +$1.79M |
|
5020
First Trust Dow Jones Select MicroCap Index Fund
FDM
$271M
| $1.42M | ﹤0.01% |
20,772
-96
| -0.5% | -$6.53K |
|
5021
Vera Bradley
VRA
$98.7M
| $1.42M | ﹤0.01% |
360,178
+305,931
| +564% | +$1.53M |
|
5022
Nurix Therapeutics
NRIX
$2.65B
| $1.42M | ﹤0.01% |
75,113
-27,753
| -27% | -$636K |
|
5023
Relay Therapeutics
RLAY
$4.33B
| $1.41M | ﹤0.01% |
343,246
+151,522
| +79% | +$825K |
|
5024
Nuveen Real Asset Income & Growth Fund
JRI
$352M
| $1.41M | ﹤0.01% |
116,308
+17,808
| +18% | +$233K |
|
5025
Strive Emerging Markets ex-China ETF
STXE
$139M
| $1.41M | ﹤0.01% |
51,057
-873
| -2% | -$25.6K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.